Fairmount Healthcare Fund II L.P.
CIK 1769651
Transactions on file
8
Open-market buys
4
Win rate (buys)
50%
4 scored
Avg % since filing (buys)
+0.6%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | 2026-05-11 | VRDN Viridian Therapeutics, Inc.\DE | Director10% | Buy | 1,176,470 | $20.00M | -7.2% | open → |
| 2025-06-11 | 2025-06-10 | VRDN Viridian Therapeutics, Inc.\DE | Director10% | Exer. | 12,500 | $153.9K | +28.1% | open → |
| 2025-06-11 | 2025-06-09 | VRDN Viridian Therapeutics, Inc.\DE | Director10% | Exer. | 1,600 | $12.5K | +102.2% | open → |
| 2025-12-08 | 2025-12-04 | CBIO CRESCENT BIOPHARMA, INC. | Director10% | Buy | 1,360,000 | $18.24M | +33.6% | open → |
| 2025-10-27 | 2025-10-23 | VRDN Viridian Therapeutics, Inc.\DE | Director10% | Buy | 454,545 | $10.00M | -28.3% | open → |
| 2025-10-09 | 2025-10-07 | ZBIO Zenas BioPharma, Inc. | Director | Buy | 316,219 | $6.01M | +4.2% | open → |
| 2025-10-08 | 2025-10-06 | JBIO Jade Biosciences, Inc. | Director10% | Grant | 1,333,126 | $12.18M | +67.8% | open → |
| 2025-09-19 | 2025-09-17 | ORKA Oruka Therapeutics, Inc. | Director10% | Grant | 333,340 | $5.00M | +365.9% | open → |
